| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00591-2232-60 | 00591-2232 | Tamoxifen Citrate | Tamoxifen Citrate | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Mar 7, 2011 | Nov 30, 2013 | No Longer Used | ||
| 50090-1941-02 | 50090-1941 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Feb 9, 2017 | Feb 9, 2017 | No Longer Used | |
| 42023-0111-01 | 42023-0111 | Estradiol Valerate | Delestrogen | 20.0 mg/mL | Hormonal Therapy | Estrogen | Intramuscular | Nov 1, 2007 | In Use | ||
| 55289-0160-42 | 55289-0160 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 10.0 mg/1 | Hormonal Therapy | Progestin | Oral | Jan 18, 2011 | In Use | ||
| 43063-0717-90 | 43063-0717 | Estradiol | Estradiol | 2.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 12, 2016 | Oct 31, 2023 | No Longer Used | |
| 23155-0685-31 | 23155-0685 | Octreotide Acetate | Octreotide Acetate | 200.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | May 25, 2022 | In Use | ||
| 50742-0391-01 | 50742-0391 | Estrogens, conjugated | Estrogens, conjugated | 1.25 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 16, 2025 | In Use | ||
| 00115-1408-08 | 00115-1408 | Methyltestosterone | Methyltestosterone | 10.0 mg/1 | Hormonal Therapy | Androgen | Oral | Sep 21, 2015 | In Use | ||
| 00046-1100-91 | 00046-1100 | Estrogens, Conjugated | Premarin | 0.3 mg/1 | Hormonal Therapy | Estrogen | Oral | Jan 1, 2006 | In Use | ||
| 00641-6175-01 | 00641-6175 | Octreotide Acetate | Octreotide Acetate | 100.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Apr 4, 2005 | In Use | ||
| 55513-0283-10 | 55513-0283 | Epoetin alfa | Epogen | 10000.0 [iU]/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Dec 5, 1994 | In Use | ||
| 54868-1010-03 | 54868-1010 | Medroxyprogesterone Acetate | Provera | Hormonal Therapy | Progestin | Oral | Jun 3, 1959 | Jun 30, 2011 | No Longer Used | ||
| 25021-0826-66 | 25021-0826 | Zoledronic Acid | Zoledronic Acid | 0.04 mg/mL | Ancillary Therapy | Bisphosphonate | Intravenous | Sep 1, 2015 | Nov 30, 2018 | In Use | |
| 60258-0866-03 | 60258-0866 | Anastrozole | Anastrozole | Hormonal Therapy | Aromatase Inhibitor | Oral | Jun 28, 2010 | Sep 11, 2013 | No Longer Used | ||
| 66267-0093-30 | 66267-0093 | Estradiol | Estradiol | 2.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 28, 1997 | Dec 13, 2018 | No Longer Used | |
| 54868-5934-00 | 54868-5934 | Estrogens, Esterified | Menest | 0.625 mg/1 | Hormonal Therapy | Estrogen | Oral | Sep 5, 2008 | In Use | ||
| 25021-0801-66 | 25021-0801 | Zoledronic Acid | Zoledronic Acid | 0.8 mg/mL | Ancillary Therapy | Bisphosphonate | Intravenous | Dec 29, 2014 | In Use | ||
| 59676-0312-00 | 59676-0312 | Erythropoietin | Procrit | 10000.0 [iU]/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug 8, 2011 | In Use | ||
| 54569-4907-00 | 54569-4907 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 28, 1997 | In Use | ||
| 23155-0689-41 | 23155-0689 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | 500.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Sep 3, 2019 | In Use | ||
| 51991-0005-33 | 51991-0005 | Exemestane | Exemestane | 25.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Dec 19, 2019 | Dec 31, 2022 | In Use | |
| 63629-3755-01 | 63629-3755 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Mar 14, 1996 | Mar 30, 2018 | No Longer Used | |
| 50090-1704-02 | 50090-1704 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Feb 18, 2015 | In Use | ||
| 43353-0687-60 | 43353-0687 | conjugated estrogens | Premarin | 0.3 mg/1 | Hormonal Therapy | Estrogen | Oral | Jan 1, 2006 | In Use | ||
| 65162-0240-03 | 65162-0240 | Exemestane | Exemestane | 25.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Dec 29, 2018 | In Use |
Found 12250 results — Export these results
Home